Five Below, Inc. Announces Participation in the 2024 ICR Conference
PHILADELPHIA, PA, Dec. 20, 2023 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality extreme-value retailer for tweens, […]
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
IRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on […]
C&F Financial Corporation Reauthorizes Share Repurchase Program
TOANO, Va., Dec. 20, 2023 (GLOBE NEWSWIRE) — The board of directors of C&F Financial Corporation (NASDAQ:CFFI) (the Corporation) has […]
LogicMark Expands Product Suite with the Launch of Freedom Alert Mini
LOUISVILLE, Ky., Dec. 20, 2023 (GLOBE NEWSWIRE) — LogicMark, Inc. (Nasdaq: LGMK) (the “Company”), creator of the most innovative personal […]
Tingo Group Announces Interim Co-CEO to Temporarily Step Down by Mutual Agreement
MONTVALE, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) — Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”), has today announced […]
Great Southern Bancorp, Inc. announces quarterly dividend of $0.40 per common share
SPRINGFIELD, Mo., Dec. 20, 2023 (GLOBE NEWSWIRE) — The Board of Directors of Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding […]
Richardson Electronics, Ltd. and Integrated Power Services (IPS) Announce Partnership to Bring Patented ULTRA3000® to Key Wind Owner Operators
LAFOX, Ill., Dec. 20, 2023 (GLOBE NEWSWIRE) — Richardson Electronics, Ltd. (NASDAQ: RELL), a global provider of engineered solutions for […]
WalkMe Survey Shows Half of Workers Don’t File Expense Reports, Leaving Billions of Dollars on the Table
SAN FRANCISCO, Dec. 20, 2023 (GLOBE NEWSWIRE) — WalkMe Inc. (NASDAQ: WKME), a leading provider of digital adoption solutions, today […]
Tonix Pharmaceuticals Announces Registered Direct Offering of up to $144 Million
Led by healthcare-focused institutional investors. $30 million financing upfront with up to an additional $114 million tied to the exercise of warrants. CHATHAM, […]
Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically Meaningful Topline Results in Second Positive Phase 3 Clinical Trial of TNX-102 SL for the Management of Fibromyalgia
Phase 3 RESILIENT study of TNX-102 SL successfully demonstrated daily pain reduction over placebo (primary endpoint, p = 0.00005) All […]
